Merck & Co., Inc. (BMV: MRK)

Market Cap	5.06T
Revenue (ttm)	1.24T
Net Income (ttm)	237.89B
Shares Out	n/a
EPS (ttm)	93.60
PE Ratio	21.28
Forward PE	n/a
Dividend	58.24 (2.90%)
Ex-Dividend Date	Dec 16, 2024

Volume	n/a
Average Volume	996
Open	2,019.46
Previous Close	2,008.00
Day's Range	2,018.00 - 2,040.00
52-Week Range	1,921.00 - 2,488.00
Beta	0.41
RSI	50.06
Earnings Date	Feb 4, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M−M−R II, Variv...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1891
• Employees: 72,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: MRK

Financial Performance

In 2023, Merck & Co.'s revenue was $60.12 billion, an increase of 1.40% compared to the previous year's $59.28 billion. Earnings were $365.00 million, a decrease of -97.49%.

Financial numbers in USD